Nandan Biomatrix Ltd, a Hyderabad-based nutraceutical company has launched its standardized medicinal plant extracts to cater the national and global pharmaceutical, nutraceutical and food and healthcare industry.
A global shift towards natural products, there is demand for preventive and promotive products. Nandan is augmenting this through its standardized phytochemicals from the medicinal plants.
The company believes in organized cultivation is the essence for the protection of the country's Bio-Diversity. Through their franchise network company have brought farming to mainstream with proper utilization of agriculture potentials. This also creates intangible assets for India through patents, thereby strengthening the economic growth in a sustainable way.
Making an announcement to this effect, V Bhaskar Rao, MD Nandan Biomatrix, said, "We develop and commercialise proprietary compounds from medicinal plants to address the unmet needs of people in the aphrodisiac, cosmetic nutritional supplements an general health product markets within the country and globally. Our integrated business strategy encompasses cultivation, R&D processing and marketing. We have more than 40 thousand acres of land under contract farming and are the first company to get into crop insurance for medicinal plants."
"Our main focus is on safed musli (chlorophytum boprivilianum), aloe vera (aloe barbadensis miller) and stevia (stevia rebaudiana). Extensive research on the herb and the recent scientific validation prove safed Musli to be natural and safe aphrodisiac, health vitalizer and immunity promoter with positive results.
According to food and agriculture organizations (FAO) of the United Nations, the international market of medicinal plants is over US $60billion per year, which is growing at the rate of 7 per cent. China and India are the two largest producers of medicinal plants, having more than 40 per cent of global biodiversity.